Peptide Vaccine Formulation Controls the Duration of Antigen Presentation and Magnitude of Tumor-Specific CD8 [electronic resource]
Producer: 20190410Description: 3464-3474 p. digitalISSN:- 1550-6606
- Adjuvants, Immunologic
- Animals
- Antigen Presentation -- immunology
- CD8-Positive T-Lymphocytes -- immunology
- Cancer Vaccines -- immunology
- Cell Line, Tumor
- Dendritic Cells -- immunology
- Inflammasomes -- immunology
- Mice
- Mice, Inbred C57BL
- Peptides -- immunology
- Tyrosine -- immunology
- Vaccination -- methods
- Vaccines, Subunit -- immunology
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.